Area of research
Infectious Diseases · Neurology
Research interest
Research interests include SARS-CoV-2 and COVID-19 Research, COVID-19 Clinical Research Studies, SARS-CoV-2 detection and testing, and Long-Term Effects of COVID-19.
Cytokinopathy with aberrant cytotoxic lymphocytes and profibrotic myeloid response in SARS-CoV-2 mRNA vaccine–associated myocarditis
SARS-CoV-2 mRNA vaccines decouple anti-viral immunity from humoral autoimmunity
An AI-powered patient triage platform for future viral outbreaks using COVID-19 as a disease model
Nonsystematic Reporting Biases of the SARS-CoV-2 Variant Mu Could Impact Our Understanding of the Epidemiological Dynamics of Emerging Variants
Neutralizing antibodies against the SARS-CoV-2 Delta and Omicron variants following heterologous CoronaVac plus BNT162b2 booster vaccination
Gut microbiome dysbiosis in antibiotic-treated COVID-19 patients is associated with microbial translocation and bacteremia
Multiscale PHATE identifies multimodal signatures of COVID-19
Plasmodium infection is associated with cross-reactive antibodies to carbohydrate epitopes on the SARS-CoV-2 Spike protein
No evidence of fetal defects or anti-syncytin-1 antibody induction following COVID-19 mRNA vaccination
Diverse functional autoantibodies in patients with COVID-19
Delayed production of neutralizing antibodies correlates with fatal COVID-19
Impact of circulating SARS-CoV-2 variants on mRNA vaccine-induced immunity
Stability of SARS-CoV-2 RNA in Nonsupplemented Saliva
High-resolution epitope mapping and characterization of SARS-CoV-2 antibodies in large cohorts of subjects with COVID-19
Tracking smell loss to identify healthcare workers with SARS-CoV-2 infection
Author Correction: Delayed production of neutralizing antibodies correlates with fatal COVID-19
Longitudinal analyses reveal immunological misfiring in severe COVID-19
Saliva or Nasopharyngeal Swab Specimens for Detection of SARS-CoV-2
MSH3 modifies somatic instability and disease severity in Huntington’s and myotonic dystrophy type 1